The KRAS gene mutation, responsible for a quarter of all cancerous tumors, has met its match. Thanks to UCSF research, a tiny ...
Researchers at Baylor College of Medicine have discovered that certain p53 mutants hijack the DNA replication machinery ...
The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer ...
At the recent CURE Educated Patient® Lung Cancer Summit, held in tandem with the 2025 PER® New York Lung Cancer Symposium, Dr ...
FOX 5 Atlanta on MSN
Hoschton woman defies odds, survives stage 4 lung cancer diagnosis
Joanne Cure, 78, survived stage 4 lung cancer after being given two years to live, crediting her faith, determination, and ...
Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS ...
The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need ...
The EMA’s recommendation follows evidence that the targeted therapy improves progression-free survival in patients whose ...
Share on Pinterest New research shows certain KRAS mutations in pancreatic cancer may improve survival rates compared to other mutations. William Taufic/Getty Images In 2020, more than 495,000 adults ...
This important study presents a technically rigorous and carefully controlled analysis of the signalling potential of cancer-associated gain-of-function Notch alleles. The work is clearly presented, ...
They found that the young mice had three times more cancer than the older ones. The young mice also had about three times as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback